Hansoh Pharmaceutical Announces Trustee's Purchase of 3 Million Shares Under Restricted Share Unit Plan in January

　　Hansoh Pharma(03692) announced that the trustee of the restricted share unit plan has notified the company that during January 2024, it has purchased a total of 3 million shares on the market for the restricted share unit plan at an average consideration of approximately HK$12.3015 per share.

Editor: Lu Yujun